nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylbutazone—SLC22A11—Methotrexate—lymphatic system cancer	0.262	0.262	CbGbCtD
Phenylbutazone—CYP2C9—Teniposide—lymphatic system cancer	0.167	0.167	CbGbCtD
Phenylbutazone—SLC22A8—Methotrexate—lymphatic system cancer	0.153	0.153	CbGbCtD
Phenylbutazone—SLC22A6—Methotrexate—lymphatic system cancer	0.106	0.106	CbGbCtD
Phenylbutazone—CYP3A4—Cytarabine—lymphatic system cancer	0.0989	0.0989	CbGbCtD
Phenylbutazone—CYP3A4—Teniposide—lymphatic system cancer	0.0974	0.0974	CbGbCtD
Phenylbutazone—CYP3A4—Mitoxantrone—lymphatic system cancer	0.0681	0.0681	CbGbCtD
Phenylbutazone—CYP3A4—Vincristine—lymphatic system cancer	0.0469	0.0469	CbGbCtD
